- Joined
- Apr 13, 2021
- Messages
- 189
- Reaction score
- 378
Hey all!
Apologies if this is not the right place to post, but I haven't seen much of any other threads on this topic. I'm currently an M2 and my goal for the past couple years has been to match Gen Surg and then do a bariatrics fellowship. I shadowed a bariatric surgeon as a pre-med and I really enjoyed it. However I've been hearing from physicians and students at my school that GLP-1 analog drugs like semaglutide, tirzepatide, etc, will kill the bariatrics industry and decrease the need for patients to get bariatric surgeries. Is this true? I wanted other thoughts on it, one of the physicians at my school said bariatric surgeries are already down 30% this year. Should I rethink another specialty before it's too late or is this all just unfounded theory, I would appreciate any other perspectives or input!
Apologies if this is not the right place to post, but I haven't seen much of any other threads on this topic. I'm currently an M2 and my goal for the past couple years has been to match Gen Surg and then do a bariatrics fellowship. I shadowed a bariatric surgeon as a pre-med and I really enjoyed it. However I've been hearing from physicians and students at my school that GLP-1 analog drugs like semaglutide, tirzepatide, etc, will kill the bariatrics industry and decrease the need for patients to get bariatric surgeries. Is this true? I wanted other thoughts on it, one of the physicians at my school said bariatric surgeries are already down 30% this year. Should I rethink another specialty before it's too late or is this all just unfounded theory, I would appreciate any other perspectives or input!